We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $156B
1-Year Est. Return 27.51%
This Fund
S&P 500
This Quarter Est. Return
+6.65%
1 Year Est. Return
+27.51%
3 Year Est. Return
+75.53%
5 Year Est. Return
+102.92%
10 Year Est. Return
+480.77%
AUM
$44.5B
AUM Growth
+$1.79B
Cap. Flow
-$1.4B
Cap. Flow %
-3.15%
Top 10 Hldgs %
6.34%
Holding
1,944
New
138
Increased
817
Reduced
733
Closed
138

Top Buys

Rank Stock Value
1
THS
Treehouse Foods
THS
+$208M
2
CNK icon
Cinemark Holdings
CNK
+$121M
3
PRGO icon
Perrigo
PRGO
+$81.1M
4
INGR icon
Ingredion
INGR
+$79.4M
5
LSTR icon
Landstar System
LSTR
+$77.3M

Top Sells

Rank Stock Value
1
MD icon
Pediatrix Medical
MD
+$146M
2
J icon
Jacobs Solutions
J
+$135M
3
EXP icon
Eagle Materials
EXP
+$106M
4
CBOE icon
Cboe Global Markets
CBOE
+$99.9M
5
JBLU icon
JetBlue
JBLU
+$76.2M

Sector Composition

Rank Sector Weight
1 Financials 18.94%
2 Industrials 14.54%
3 Technology 14.31%
4 Consumer Discretionary 11.03%
5 Healthcare 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NWS icon
1726
News Corp Class B
NWS
$16.9B
$27K ﹤0.01%
2,009
-55
-3% -$765
RNR icon
1727
RenaissanceRe
RNR
$13.3B
$27K ﹤0.01%
200
+86
+75% +$12.1K
JBGS
1728
JBG SMITH
JBGS
$818M
$25K ﹤0.01%
+744
New +$25.2K
RARE icon
1729
Ultragenyx Pharmaceutical
RARE
$2.45B
$24K ﹤0.01%
443
MLNX
1730
DELISTED
Mellanox Technologies, Ltd.
MLNX
$23K ﹤0.01%
478
ADXS
1731
DELISTED
Advaxis Inc
ADXS
$22K ﹤0.01%
354
TLGT
1732
DELISTED
Teligent, Inc
TLGT
$22K ﹤0.01%
331
SIMO icon
1733
Silicon Motion
SIMO
$8.6B
$21K ﹤0.01%
435
STML
1734
DELISTED
Stemline Therapeutics, Inc.
STML
$21K ﹤0.01%
1,858
ACAD icon
1735
Acadia Pharmaceuticals
ACAD
$4.43B
$19K ﹤0.01%
513
CLLS
1736
Cellectis
CLLS
$277M
$19K ﹤0.01%
683
LXRX icon
1737
Lexicon Pharmaceuticals
LXRX
$1.03B
$19K ﹤0.01%
1,557
SKT icon
1738
Tanger
SKT
$4.67B
$19K ﹤0.01%
765
CDTX
1739
DELISTED
Cidara Therapeutics
CDTX
$18K ﹤0.01%
110
LCNB icon
1740
LCNB Corp
LCNB
$282M
$18K ﹤0.01%
865
ADMS
1741
DELISTED
Adamas Pharmaceuticals
ADMS
$18K ﹤0.01%
845
-593
-41% -$10.9K
MTZ icon
1742
MasTec
MTZ
$21.1B
$17K ﹤0.01%
+356
New +$15.5K
BVH
1743
DELISTED
Bluegreen Vacations Holding Corporation
BVH
$17K ﹤0.01%
+471
New +$16K
WRI
1744
DELISTED
Weingarten Realty Investors
WRI
$17K ﹤0.01%
535
AGEN
1745
Agenus
AGEN
$312M
$16K ﹤0.01%
188
ARWR icon
1746
Arrowhead Research
ARWR
$11.9B
$16K ﹤0.01%
3,599
CIM
1747
Chimera Investment
CIM
$1.04B
$16K ﹤0.01%
275
CLVS
1748
DELISTED
Clovis Oncology, Inc.
CLVS
$16K ﹤0.01%
189
OLBK
1749
DELISTED
Old Line Bancshares, Inc.
OLBK
$16K ﹤0.01%
582
CASH icon
1750
Pathward Financial
CASH
$1.86B
$15K ﹤0.01%
567
-4,851
-90% -$125K

Similar funds

Victory Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Victory Capital Management held 1,944 positions worth $44.5B, up 4.2% from $42.7B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.

Victory Capital Management withdrew a net $1.4B in Q3 2017, closing 138 positions and reducing 733 holdings. Its most notable exit was Pediatrix Medical, an estimated $146M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 19% a quarter earlier, followed by Industrials and Technology.

Against the trend, Victory Capital Management opened a new position in Landstar System worth $86.7M.

  • Victory Capital Management's largest Q3 2017 buy was Landstar System: 870,300 shares worth $86.7M.
  • Victory Capital Management added most to Treehouse Foods in Q3 2017, an estimated $208M increase.
  • Victory Capital Management's biggest Q3 2017 reduction was Jacobs Solutions, cutting an estimated $135M.
  • Victory Capital Management fully exited Pediatrix Medical in Q3 2017, selling an estimated $146M.
  • Victory Capital Management's ten largest holdings make up 6.3% of its $44.5B portfolio in Q3 2017.
  • Victory Capital Management opened 138 new positions and closed 138 in Q3 2017.
  • Victory Capital Management's portfolio value rose 4.2% quarter-over-quarter to $44.5B.

Based on Victory Capital Management's 13F filing for Q3 2017, filed 27 Oct 2017.